NDC 68462-295
Trandolapril and Verapamil Hydrochloride 2 mg / 180 mg tablet, film coated, extended release
On the label: Glenmark Pharmaceuticals Inc., USA.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Goa, India | Makes it and tests it | Problems found, fixed voluntarilyJun 30, 2026 · 7 inspections, 1 with FDA action |
Recalls
- Aug 14, 2023 · Class III · Glenmark Pharmaceuticals Inc., USA
Subpotent: Out of Specification for Assay Test at the 3-month time point.
Lots: Batch # 19224744
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Trandolaprilat and Verapamil: every company that makes it
- Form
- tablet, film coated, extended release, oral
- Strength
- 2 mg / 180 mg
- Approval
- ANDA ANDA079135
- On the market since
- Feb 25, 2015
- Package NDCs
68462-295-0168462-295-1068462-295-90- Official label
- DailyMed (National Library of Medicine), updated Jan 29, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?